NVRO Nevro Corp

Price (delayed)

$121.29

Market cap

$4.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.96

Enterprise value

$4.25B

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
NVRO's quick ratio has surged by 140% since the previous quarter and by 123% year-on-year
The debt has dropped by 50% since the previous quarter and by 49% year-on-year
The equity has contracted by 4.3% YoY and by 2.1% from the previous quarter

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
34.87M
Market cap
$4.23B
Enterprise value
$4.25B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.77
Price to sales (P/S)
10.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.38
Earnings
Revenue
$409.13M
EBIT
-$42.1M
EBITDA
-$33.97M
Free cash flow
$868,000
Per share
EPS
-$1.96
Free cash flow per share
$0.02
Book value per share
$10.31
Revenue per share
$11.75
TBVPS
$17.22
Balance sheet
Total assets
$599.54M
Total liabilities
$241.17M
Debt
$163.85M
Equity
$358.38M
Working capital
$482.75M
Liquidity
Debt to equity
0.46
Current ratio
7.53
Quick ratio
6.27
Net debt/EBITDA
-0.51
Margins
EBITDA margin
-8.3%
Gross margin
70%
Net margin
-16.7%
Operating margin
-10.4%
Efficiency
Return on assets
-9.3%
Return on equity
-18.3%
Return on invested capital
-5.8%
Return on capital employed
-8%
Return on sales
-10.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
0.85%
1 week
3.96%
1 month
-2.5%
1 year
-25.25%
YTD
-29.93%
QTD
4.22%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$409.13M
Gross profit
$286.39M
Operating income
-$42.7M
Net income
-$68.27M
Gross margin
70%
Net margin
-16.7%
The operating margin has soared by 57% YoY and by 40% from the previous quarter
NVRO's operating income has soared by 50% YoY and by 31% QoQ
The net margin is up by 39% year-on-year and by 31% since the previous quarter
The net income has grown by 30% YoY and by 22% from the previous quarter

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
11.77
P/S
10.32
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.38
The EPS has increased by 35% year-on-year and by 23% since the previous quarter
NVRO's P/B is 18% below its last 4 quarters average of 14.3 but 5% above its 5-year quarterly average of 11.2
The equity has contracted by 4.3% YoY and by 2.1% from the previous quarter
The P/S is 27% lower than the last 4 quarters average of 14.1 but 17% higher than the 5-year quarterly average of 8.8
The revenue has grown by 14% YoY and by 13% from the previous quarter

Efficiency

How efficient is Nevro business performance
The company's return on invested capital has surged by 64% YoY and by 31% QoQ
The return on sales has surged by 55% year-on-year and by 39% since the previous quarter
NVRO's return on equity has surged by 53% year-on-year and by 21% since the previous quarter
The ROA has grown by 49% YoY and by 18% from the previous quarter

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 149% greater than its total liabilities
Nevro's current ratio has surged by 151% QoQ and by 132% YoY
NVRO's quick ratio has surged by 140% since the previous quarter and by 123% year-on-year
The debt is 54% smaller than the equity
The debt has dropped by 50% since the previous quarter and by 49% year-on-year
The debt to equity has decreased by 49% QoQ and by 47% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.